Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States
- 22 November 2016
- journal article
- transfusion practice
- Published by Wiley in Transfusion
- Vol. 57 (2), 289-295
- https://doi.org/10.1111/trf.13934
Abstract
BACKGROUND Transfusion of blood products is a key component of the supportive management in patients with acute leukemia (AL). However high‐quality trial evidence and clinical outcome data to support specific transfusion goals for blood products for patients with AL remain limited leading to diverse transfusion practices. The primary objective of this study was to determine the spectrum of transfusion patterns in a variety of care settings among providers who treat AL patients. STUDY DESIGN AND METHODS A 31‐question survey queried providers caring for AL patients about the existence of institutional guidelines for transfusion of blood products, transfusion triggers for hemoglobin (Hb), platelets (PLTs), and fibrinogen in various settings including inpatient and outpatient and before procedures. RESULTS We analyzed 130 responses and identified divergent transfusion Hb goals in hospitalized and ambulatory patients, fibrinogen goals for cryoprecipitate transfusions, and variation in practice for use of certain PLTs and red blood cell products. The least variable transfusion patterns were reported for PLT goals in thrombocytopenia and in the setting of invasive procedures such as bone marrow biopsy and lumbar punctures. CONCLUSIONS This survey confirmed wide variations in blood product transfusion practices across several clinical scenarios in patients with AL. The findings emphasized the need for large prospective randomized trials to develop standardized evidence‐based guidelines for blood product transfusions in patients with AL with the goal of limiting unnecessary transfusions without compromising outcomes.Keywords
Funding Information
- National Cancer Institute
- National Institutes of Health
This publication has 19 references indexed in Scilit:
- Activity‐based costs of plasma transfusions in medical and surgical inpatients at a US hospitalVox Sanguinis, 2016
- Liberal or Restrictive Transfusion after Cardiac SurgeryThe New England Journal of Medicine, 2015
- Platelet transfusion: a systematic review of the clinical evidenceTransfusion, 2014
- Transfusion Strategies for Acute Upper Gastrointestinal BleedingThe New England Journal of Medicine, 2013
- Management of bleeding and coagulopathy following major trauma: an updated European guidelineCritical Care, 2013
- Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised studyThe Lancet, 2012
- Liberal or Restrictive Transfusion in High-Risk Patients after Hip SurgeryThe New England Journal of Medicine, 2011
- Feasibility of a restrictive red-cell transfusion policy for patients treated with intensive chemotherapy for acute myeloid leukaemiaTransfusion Medicine, 2004
- The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBCTransfusion, 2004
- The Threshold for Prophylactic Platelet Transfusions in Adults with Acute Myeloid LeukemiaThe New England Journal of Medicine, 1997